CENTOGENE GmbH Rostock: all 57 studies
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Investigating the Impact of Environmental Factors on the Transcriptomics Profile in Healthy IndividualsCompletedNCT06040008
- Omics Gaucher Study: Multiomic ApproachActive, not recruitingNCT05526664
- Epidemiological Study in FRONtoTemporal DementiaCompletedNCT05075187
- Unraveling Genetics of HypoPhosPhatasia (HPP Genetics)CompletedNCT04925804
- Biomarker for Friedreich's Ataxia (BioFridA)Status unknownNCT04548921
- COVID-19 Epidemic Response StudyWithdrawnNCT04357496
- Biomarkers for Inborn Errors of MetabolismCompletedNCT04098198
- Induced Pluripotent Stem Cells for the Development of Novel Drug Therapies for Inborn Errors of Metabolism (iPSC-IEM)Status unknownNCT04097275
- Hereditary Angioedema Kininogen AssayTerminatedNCT04091113
- Induced Pluripotent Stem Cells for Niemann Pick DiseaseCompletedNCT03883750
- Establishment of Human Cellular Disease Models for Morquio DiseaseCompletedNCT03872713
- Peptide-based Immunization for Colon- and and Pancreas-carcinomaCompletedNCT03871790
- Establishment of Human Cellular Disease Models for Wilson DiseaseCompletedNCT03867526
- Rostock International Parkinson's Disease Study (ROPAD)CompletedNCT03866603
- Pyruvate Kinase Deficiency Epidemiological Study (PIECE)CompletedNCT03866590
- European Alpha-Mannosidosis ParticipantTerminatedNCT03651245
- Epidemiological Analysis for Hereditary Angioedema DiseaseCompletedNCT03558009
- Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1 (BioTyrosin)WithdrawnNCT03284658
- Biomarker for Mannosidosis Disease (BioMannosidosis)WithdrawnNCT03264040
- TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive SubjectsCompletedNCT03237494
- Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)WithdrawnNCT03198897
- Biomarker for Hyaline Fibromatosis Syndrome (BioHFS)WithdrawnNCT03196115
- Biomarker for Hereditary AngioEdema DiseaseCompletedNCT03029728
- Biomarker for Duchenne Muscular DystrophyCompletedNCT02994030
- Biomarker for Creatine Deficiency Syndromes (BioCDS)WithdrawnNCT02934854
- Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)WithdrawnNCT02837523
- Biomarker for Patients With Fabry Disease (BioFabry)WithdrawnNCT02778295
- Biomarker for Alport Syndrome (BioAlport)TerminatedNCT02718027
- Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP)WithdrawnNCT02713880
- Biomarker for Gilbert Disease (BioGilbert)WithdrawnNCT02712138
- Biomarker for Cystic FibrosisTerminatedNCT02710383
- Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)TerminatedNCT02654340
- Biomarker for Hypophosphatasia Disease (BioHypophos)WithdrawnNCT02603042
- Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher DiseaseCompletedNCT02416661
- Biomarker for Glycogen Storage Diseases (BioGlycogen)WithdrawnNCT02385162
- Biomarker for Wolman Disease (BioWolman)WithdrawnNCT02383641
- Biomarker for Hurler Disease (BioHurler)WithdrawnNCT02298712
- Biomarker for Sly Disease (MPS VII) (BioSly)WithdrawnNCT02298699
- Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo)WithdrawnNCT02298686
- Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML)WithdrawnNCT02298673
- Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)WithdrawnNCT02298647
- Biomarker for Farber Disease (BioFarber)WithdrawnNCT02298634
- Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP)CompletedNCT01705626
- Biomarker for Metachromatic Leukodystrophy (BioMeta) DiseaseWithdrawnNCT01536327
- Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)WithdrawnNCT01458613
- Biomarker for Morquio Disease (BioMorquio)WithdrawnNCT01457456
- Biomarker for Pompe Disease (BioPompe)WithdrawnNCT01457443
- Fabry and Cardiomyopathy (FaCard)WithdrawnNCT01429597
- Biomarker for Krabbe Disease (BioKrabbe)WithdrawnNCT01425489
- Biomarker for Gaucher Disease: BioGaucher (BioGaucher)WithdrawnNCT01331642
- Biomarkers for Hunter SyndromeTerminatedNCT01330277
- Biomarker for Niemann Pick Type C Disease (BioNPC)WithdrawnNCT01306604
- Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype CorrelationCompletedNCT01272687
- Prevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple SclerosisCompletedNCT01271699
- The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry DiseaseCompletedNCT01268241
- Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke PatientsCompletedNCT00414583
- Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke RehabilitationCompletedNCT00413595